DNA methyltransferase I is the primary eukaryotic DNA methyltransferase engaged in maintenance of CpG 5 DNA methylation patterns across the genome. Alteration of CpG methylation patterns and levels is a frequent and significant occurrence across many cancers, and targeted inhibition of Dnmt1 has become an approach of choice for select malignancies. There has been significant interest both in the methyltransferase activity as well as methylation-independent functions of Dnmt1. A previously generated hypomorphic allele of Dnmt1 in HCT116 colorectal cancer cells has become an important tool for understanding Dnmt1 function and how CpG 10 methylation patterns are modulated across the genome. Colorectal cancer cells with the Dnmt1 hypomorphic allele carry a homozygous deletion of exons 3 to 5 of Dnmt1, resulting in greatly reduced Dnmt1 protein expression whilst still exhibiting a limited functional activity and methyltransferase ability. Although this cell model of reduced Dnmt1 levels and function have been used to study the downstream effects on the epigenome and transcriptome, the broader effects of the Dnmt1 hypomorph on the proteome and wider cell 15 signalling are largely unknown.
INTRODUCTION
DNA methyltransferase 1 (Dnmt1) is the most abundant DNA methyltransferase in somatic cells [1] [2] [3] , and mediates the fidelity of CpG methylation patterns in newly generated daughter cells [3, 4] . Loss of Dnmt1 is embryonically lethal with mouse embryonic stem cells lacking the catalytic function of Dnmt1 arresting prior to 10 the 8-somite stage [2] and complete knockout of Dnmt1 in cultured cells results in G2/M cell cycle checkpoint arrest followed by apoptosis [2, 5] . Dnmt1 protein and its methyltransferase activity are required to maintain an undifferentiated and inexhaustible proliferative state in many stem cells and knockdown of Dnmt1 subsequently leads to premature differentiation of cells and eventually apoptosis as a result of loss of methylation markers [6] . Increased abundance of Dnmt1 protein has been shown in several cancer types, and 15 typically correlates with tumour progression and altered genomic CpG methylation levels [7] [8] [9] [10] . Dysregulated DNA methylation activity results in cancer-specific methylation-dependent suppression of targeted gene expression, acting in a similar way to mutations that adversely affect tumour suppressor genes in developing tumour cells [4, 11, 12] .
Increasing evidence indicates that Dnmt1 also has a range of DNA methyltransferase-independent functions. It 20 has previously been shown that genes with changes in expression in response to Dnmt1 knockdown did not always contain CpG islands or show changes in their methylation status [1] . Through its interaction with Ubiquitin like with PHD and ring finger domains 1 (Uhrf1), Lysine acetyltransferase 5 (Tip60), and Histone deacetylase 1 (HDAC1), Dnmt1 can modulate acetylation, as well as suppress gene transcription as part of a regulatory complex with Chromodomain helicase DNA binding protein 4 (CHD4), and HDAC1 [13, 14] . Dnmt1 5 can function as a scaffold protein in transcription repression complexes independent of its methyltransferase catalytic domain, though its interaction with lysine demethylase 1A (LSD1). We previously showed that Dnmt1 can interact with Beta-Catenin in the nucleus of colorectal cancer cells leading to mutual stabilization of both proteins and increased CpG methylation and oncogenic Wnt signalling [15] .
Due to the critical functions of Dnmt1, viable models of gene knockout and protein knockdown are limited. 5 Chemical-mediated degradation of Dnmt1 is usually induced by treatment with the cytosine chemical analog 5-Azacitidine or its deoxy analog decitabine, which integrate into DNA as a substitute for cytosine, inhibiting Dnmt1 ability to donate its methyl group and resulting in Dnmt1 degradation [16, 17] . Dnmt1 mutant alleles encoding proteins with altered methyltransferase activity or reduced abundance have been of great interest in the field, allowing cells to be propagated and the function of Dnmt1 to be studied. [18] generated a series of 10 Dnmt1 mutant cell models derived from the colorectal cancer cell line HCT116, although designated Dnmt1-/cells. [19] further characterized these cell lines as expressing a lower abundance (20%) of truncated hypomorph protein (Dnmt1 ∆3-5 ) approximately 17kDa smaller than the WT protein. This homozygous HCT116-Dnmt1 ∆3-5 cell line has the DMAP1 interaction domain and the PCNA interaction domain deleted at the Nterminus by the insertion of a hygromycin resistance gene [18] . This mutant protein results in a 96% decrease 15 in methyltransferase activity, although it retains its catalytic domain and DNA binding ability and genomic methylation levels are only decreased by approximately 20% [18] [19] [20] . These mutant cell lines have been used as models to study the effect of Dnmt1 on global methylation levels and the reactivation of CpG island promoter controlled gene expression [21] . In addition [22] found that HCT116-Dnmt1 ∆3-5 cells showed reduced Ca2+-dependent cell adhesion, indicating dysregulation of E-Cadherin cell-cell adhesion junctions, this effect 20 was independent of Dnmt3b signalling. Further characterization indicated a reduced abundance of E-Cadherin protein, and a re-localization of Beta-Catenin away from the plasma membrane, resulting in activated canonical Wnt signalling. This phenotype was specific to HCT116-Dnmt1 ∆3-5 cells suggesting a DNAmethyltransferase-independent role for the N-terminal domain of Dnmt1 in cell-cell adhesion maintenance [22] . 25 
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To investigate how the hypomorphic Dnmt1 allele impacts on cellular phenotype and on the cellular proteome we undertook a comprehensive proteomic analysis of HCT116-Dnmt1 ∆3-5 cells. Analysis of signalling networks and pathways that were dysregulated in the HCT116-Dnmt1 ∆3-5 nuclear proteomic profile identified alteration of the proteasome, cell adhesion junctions, cytoskeletal architecture and EMT were identified. We focused on further investigation of the very clear and significantly differential signature of EMT activation observed in the 5 hypomorphic Dnmt1 cells and of the significantly altered profile of Beta-catenin subcellular re-localization. To understand whether altered expression of EMT related proteins is a consequence of reduced Dnmt1 protein levels or is a direct result of the mutant Dnmt1 ∆3-5 protein, shRNA knockdowns of WT Dnmt1 were performed.
These experiments showed that reducing Dnmt1 protein levels did not result in the induction of EMT marker proteins as observed in Dnmt1 hypomorphic cells. In addition, expression of wild-type Dnmt1 protein in 10 hypomorphic Dnmt1 cells was not able to alter the EMT signature seen in these cells, suggesting that the EMT marker signature in Dnmt1 hypomorphic cells is a result of the presence of the hypomorphic protein rather than reduced protein abundance. In summary, we have identified multiple altered pathways and processes in a key model of Dnmt1 function in cancer cells, furthering our understanding and appreciation of the methylation-dependent and independent roles of this key protein.
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RESULTS
The HCT116-Dnmt1 ∆3-5 cell-line originally developed by Rhee et al., (2000) [18] and characterised by Egger et al., (2006) [19] were grown in culture and Dnmt1 status of the hypomorph cell line was confirmed by PCR using primers specific to exons 1 and 6 of genomic WT Dnmt1 ( Table 1) . Amplification of the endogenous 20 Dnmt1 in WT HCT16 cells and HCT116-Dnmt1 ∆3-5 cells confirmed a product of reduced size in the HCT116-Dnmt1 ∆3-5 cells as described by Egger et al., (2006) (Figure 1A and 1B). Further characterization of the endogenous protein was carried out by Western blot analysis ( Figure 1C and 1D). HCT116-Dnmt1 ∆3-5 cells showed a signal with reduced protein size and abundance compared to WT Dnmt1 in WT HCT116 cells, as previously shown by Egger et al., (2006) and we confirmed that two different anti-Dnmt1 antibodies gave the 7 same result ( Figures 1C and 1D ). We also investigated two known Dnmt1 interaction partners, Usp7 [23] and Beta-Catenin [15] . No effect was observed on overall Usp7 protein abundance; however, there was an evident decrease in Beta-catenin abundance in the HCT116-Dnmt1 ∆3-5 cell line ( Figure 1C ).
To broadly characterize proteome-wide altered protein expression in HCT116-Dnmt1 ∆3-5 cells we performed quantitative LC-MS/MS analysis on replicate nuclear samples from HCT116-Dnmt1 ∆3-5 and HCT116 wild-type 5 cells and characterised these same samples with Western blots as shown in Figure 1D . Data-independent quantitative mass spectrometry analysis identified a total of 3,678 proteins, of which 383 were found to be significantly differentially abundant (P value = <0.05). The sets of significantly differential proteins were analysed for enrichment of Gene Ontology (GO) terms. GO terms were ranked according to their significance in the HCT116 wild-type or HCT116-Dnmt1 ∆3-5 cells and the most distinct terms are presented in Figures 2A and 10 2B. In particular, we noted the significant differences between the wild-type cells and hypomorph cells of their expression of proteasomal components (increased in wild-type cells), dys-regulation of metabolism (increased glyoxylate cycle, fatty acid and RNA metabolism in hypomorph cells) and cell-cell adhesion (increased expression of proteins in wild-type cells).
The protein with the largest increased abundance in HCT116-Dnmt1 ∆3-5 cells was Vimentin (Log2 FC = 4.50), an 15 intermediate filament protein with key roles in cytoskeletal architecture and cell signalling. In addition to this the top 50 proteins with increased differential abundance were enriched for proteins involved in amino acid metabolism, such as ACAT1, and DECR1, confirming the proposed dysregulation of amino acid metabolism in HCT116-Dnmt1 ∆3-5 cells.
The protein with the largest decrease in abundance in HCT116-Dnmt1 ∆3-5 nuclear proteome included KRT19, 20 and KRT8 that are involved in cellular developmental processes, several members of the catenin protein family that enrich for the dysregulation of cell adhesion signalling, and members of the proteasome (prosoma, macropain) family that constitute proteosomal protein complexes. Large differential abundance changes in these proteins confirm the proposed dysregulation of protein ubiquitination-mediated degradation, cell adhesion, and cellular development as identified in GO biological process analysis. 25 As shown in Figure 2C , we identified a network of proteins that co-complex at the cell membrane forming cellcell adhesion contacts via adherens junctions. Beta-catenin has previously shown to be an interaction partner of Dnmt1 in a mutual stabilizing interaction [15] . Alpha-Catenin, Delta-Catenin, and E-Cadherin form adherens junctions, connecting intracellular actin filaments to adjacent cells as one of the primary forms of cell-cell contacts in epithelial cells. All of the proteins in this complex exhibited decreased protein abundance in the Three myosin proteins were found to be dysregulated in HCT116-Dnmt1 ∆3-5 cells, that regulate cytoskeletal architecture, migration and cell polarity [24] . In addition, these have been shown to interact with Arpc5l which 10 facilitates actin polymerization, and POTEE which has been found up regulated in numerous cancer tissues and cell lines [25] . Taken together this interaction network regulates cellular architecture and structure, dysregulation of which is a key hallmark of tumourigenesis [26] We observed dramatically altered expression of Vimentin (UniProt: P08670) between the HCT116 wild-type and HCT116-Dnmt1 ∆3-5 cells and the fold-change of this protein was the largest statistically significant change 15 observed across the complete dataset (log2 fold change=4.50; p-value = 1 x 10-3). Western blots of nuclearenriched and whole cell lysates of key EMT markers are shown in Figure 3A and 3B, and corresponding ratios and p-values from the mass-spectrometry data are shown in Figure 3 . Western blot analysis indicated that there was only low levels of Vimentin protein present in HCT116 cells, and significant expression of Vimentin in both the nuclear-enriched and whole cell protein samples extracted from HCT116-Dnmt1 ∆3-5 cells, in 20 agreement with a previous study [22] . Vimentin protein levels have previously reported to be low in WT HCT116, with western blot analysis with some antibodies producing negligible protein bands [27] . Vimentin is an intermediate filament protein, regulating cell motility, organelle and membrane-associated protein organization [25] . Significantly increased Vimentin expression is reminiscent of the typical phenotype shown by the process of epithelial to mesenchymal transition (EMT) and we next performed Western blot analysis of 9
other key EMT protein markers. HCT116-Dnmt1 ∆3-5 cells showed substantially decreased E-cadherin protein abundance in both nuclear and whole cell protein extracts when compared to HCT116 cells (Figure 3A) although N-cadherin protein abundance was unaltered (and not detected in the mass-spectrometry experiments). The Western blots confirmed the mass-spectrometry data, whereby no peptides corresponding to E-cadherin were detected in samples from the HCT116-Dnmt1 ∆3-5 cells. 5 Following identification of dysregulation of key phenotypic EMT markers, we investigated the EMT-associated transcription factors Slug, Snail, Zeb1 and Twist ( Figure 3D ). Western blot analysis of these transcription factors showed that Slug, Snail and Twist are clearly elevated in HCT116-Dnmt1 ∆3-5 cells compared to HCT116 wild-type cells, suggesting that activation of these transcription factors may be the drivers of altered Ecadherin and Vimentin expression. Slug and Snail have been shown to induce EMT signalling in TGFß treated 10 CRC cell lines in tandem with Zeb1 and Twist signalling, however these transcription factors can act independently of one another to induce EMT transformation [27] . Increased protein expression and nuclear localization of Snail mediates the cadherin switch, resulting in the EMT phenotype of decreased E-Cadherin and increase N-Cadherin abundance [28] . E-Cadherin transcription can also be repressed by the binding of Slug, Zeb1, and Twist to its promoter, resulting in decreased protein abundance, these transcription factors 15 also promote the increase in protein abundance of N-Cadherin, facilitating the progression of EMT [29] . We have therefore shown that an increase in Slug and Snail protein abundance in HCT116-Dnmt1 ∆3-5 cells may drive the partial cadherin switch between E-Cadherin and N-Cadherin that is evident in these cell lines.
Beta-Catenin is another important driver of EMT and Vimentin expression, for which we observed significantly differential abundance in the mass-spectrometry data (log2 fold decrease=-2.2 in HCT116-Dnmt1 ∆3-5 ; p-20 value=1 x10-3) and by Western blot ( Figure 1C ). Beta-catenin is also a nuclear interaction partner of Dnmt1 in wild-type HCT116 cells [15] and we therefore analysed the subcellular distributions of Dnmt1 and Beta-catenin as shown in Figure 4A . Nuclear and cytosolic protein lysates from HCT116-Dnmt1 ∆3-5 and wild-type cells were analysed and as expected Dnmt1 protein found to be significantly enriched in the nuclear samples [30] .
Interestingly a similar ratio of Dnmt1 protein localization was not observed in HCT116-Dnmt1 ∆3-5 cells, 25 although there is an overall lower protein expression of Dnmt1 ∆3-5 in these cells, there was approximately the same amount of protein present in both the nuclear enriched and cytosol enriched protein samples. This would suggest that even though the Dnmt1 ∆3-5 protein retains its nuclear localization signal the distribution of the protein throughout the cellular compartments is modified in response to the loss of exons 3 to 5. To further investigate this finding, we used immunolocalization and confocal microscopy to visualize Dnmt1 and 5 Beta-catenin sub-cellular distribution as shown in Figure 4B . Dnmt1 present in the cytosol of these cell lines also co-localizes with Beta-Catenin, indicating that this interaction is not exclusive to the nucleus in this cell line. In alignment with the Western blot analyses, immunofluorescent imaging indicated that Beta-Catenin distribution was more diffuse throughout the HCT116-Dnmt1 ∆3-5 cells, with a larger proportion of the protein present in the cytoplasm compared to the WT HCT116 cell line. 15 We next investigated whether the reduced levels of Dnmt1 protein in HCT116-Dnmt1 ∆3-5 cells was associated with the observed induction of EMT protein markers. Knock-down of Dnmt1 protein in wild-type HCT116 cells was achieved following transfection with 5 individual shRNA constructs as well as a mix of all 5 of these shRNA constructs, using a transfected scrambled shRNA construct as a control. Samples were analysed by western blot with WT HCT116 and HCT116-Dnmt1 ∆3-5 protein samples as reference controls and a GFP plasmid 20 transfected cell line as an independent transfection control. Western blots were used to determine protein abundance of the EMT markers Vimentin, E-Cadherin, and N-Cadherin. All shRNA constructs resulted in a decreased protein abundance of Dnmt1, apart from construct 1 (shDNMT1-1), the transfection protocol did not affect Dnmt1 protein abundance levels, as shown by the shDNMT1 (-ve) construct and GFP plasmid transfected HCT116 cell line ( Figure 5A ). Reduction of Dnmt1 by shRNA knockdown did not increase Vimentin 11 expression in WT HCT116 cell lines. Similarly, no alterations to either E-Cadherin ( Figure 5B ) or N-Cadherin ( Figure 5C ) protein abundance by the shRNA-mediated knock-down of Dnmt1 protein expression were observed. We also tested whether expression of full-length Dnmt1 protein in HCT116-Dnmt1 ∆3-5 cells would result in decreased Vimentin expression seen in HCT116 wild-type cells ( Figure 5D ). Expression of the full length DNMT1 construct was identifiable in the HCT116-Dnmt1 ∆3-5 cells on the western blot as a separate band 5 with increased size, comparable to that shown in WT HCT116 cells. Protein samples from the Dnmt1 recovery experiment did not show a reduction in Vimentin protein abundance when compared to HCT116-Dnmt1 ∆3-5
cells. Similar rescue experiments by [22] indicate that E-Cadherin expression can be reversed following expression of exogenous WT Dnmt1, however this paper did not stipulate the duration of WT Dnmt1 expression required to show this, nor did they investigate the effect of WT Dnmt1 on the ability to repress PCR analysis of Dnmt1 cDNA in HCT116 and HCT116-Dnmt1 ∆3-5 cells. 10 RNA was extracted from HCT116 and HCT116-Dnmt1 ∆3-5 cells using TRIzol™ Reagent (Invitrogen) according to the manufactures protocol and stored at -80oC until required. Reverse transcriptase of RNA was perform using GoScript™ Reverse Transcription System (Promega) according to the manufacturers protocol. cDNA was stored at -20oC until analysed by polymerase chain reaction using GoTaq®G2 DNA polymerase (Promega) according to the manufacturers protocol. Annealing temperature was calculated on Tm of primer set (custom oligos, IDT) 15 detailed in Table 1 . PCR products were then analysed using gel electrophoresis, on a 0.9% agarose gel using GelRed® Nucleic Acid Gel Stain (Biotium) and imaged using a G:BOX Ef imaging system (Syngene) and analysed using SnapGene software. 
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MATERIALS AND METHODS
Cell line culture and sample extraction
Primer Sequence 5'-3' Tm ( o C)
Proteomic sample preparation and mass spectrometry
Gene Ontology and protein interaction network analyses
Protein abundance (femtomoles on column) was used to identify significantly differential proteins (Student's T-test) log2 ratio (hypomorph: wild-type) was computed. Graphical analysis of normalized mass spectrometry nuclear proteomic profiles was analysed using the R package ggplot2 and Morpheus GUI (https://software.broadinstitute.org/morpheus). Gene Ontology (GO) term enrichment was computed for the 5 sets of significant (p<0.05) proteins using the Pathway Studio database (Elsevier), version 9.0. The most significantly differential GO terms were identified using the Rank Mobility Index for ranked terms between the hypomorph and wild-type datasets. Pathway Studio database network nodes and edges were supplemented by addition of STRING database interactions. Differentially abundant proteins were analysed using String DB, interaction networks were modified using internal settings for evidence-based interaction sources, and 10 interactions represented based on their molecular action [36] . Interaction networks were than manually adapted to represent differential protein abundance as shown in nuclear proteomic profiling data of HCT116 and HCT116-Dnmt1 ∆3-5 cells.
Immunofluorescence microscopy 15 Cells were grown in 6 well plates (corning) and cell fixed using 4% paraformaldehyde and quenched using 50mM NH4Cl2. Cells were then permeabilise with 0.1% Triton100 and blocked in 10% normal goat serum for 30 minutes. Slides were then incubated with primary antibodies overnight at a dilution of 1:100 (see table 2 for antibody details). Slides were then incubated with secondary antibodies for 30 minutes at a dilution of 1:15,000 (Anti-Rabbit IgG 488 (Sigma SAB4600234) and Anti-Mouse IgG 555 (SAB4600068)). Coverslips were 20 then mounted overnight at 4oC using ProLongTM Gold antifade mountant with DAPI (ThermoFisher P36931).
Slides were then visualized using a Leica TCS SP8 microscope, aquired using LAS X Core software (V3.3.0) and analsyed using Fiji (released May 2017) with MBF "ImageJ for Microscopy" plugin (Dec 2009 release).
Generation of shRNA-containing lentivirus. 25 One million Hek293 FT cells were plated per well in a 6 well culture plate (Corning) and transfected 2 hours post-seeding with a 4-2-1 ratio of Plasmid: gagpol:vsvg, PEI transfection reagent (Sigma) in 100µl serum-free DMEM (LifeTech). Cells were transfected overnight, and media replaced the following morning with 2ml DMEM, 10%FCS, and 5% PenStrep. Cells were incubate for a further 24 hours before lentiviral-containing media was removed and filtered through a 0.45µm filter, lentiviral-containing media was then stored at -80oC 5 until use. 
shDNMT1 ID
Product ID Company Clone name Sequence 5'-3' Vector
shDNMT1- 1 TRCN0000232748 Sigma- Aldrich NM_001379.1- 1714s21c1 CCCGAGTATGCGCCCATATTT pLKO_TRC005 (AddGene) shDNMT1- 2 TRCN0000232747 Sigma- Aldrich NM_001379.1- 373s21c1 TTGAATCTCTTGCACGAATTT pLKO_TRC005 (AddGene) shDNMT1- 3 TRCN0000232749 Sigma- Aldrich NM_001379.1- 2340s21c1 CGATGAGGAAGTCGATGATAA pLKO_TRC005 (AddGene) shDNMT1- 4 TRCN0000232750 Sigma- Aldrich NM_001379.1- 3209s21c1 ACCGAATTGGCCGGATCAAAG pLKO_TRC005 (AddGene) shDNMT1- 5 TRCN0000232751 Sigma- Aldrich NM_001379.1- 5229s21c1 GAGGTTCGCTTATCAACTAAT pLKO_TRC005 (AddGene)
Dnmt1 recovery experiment
Transfection of HCT116 and HCT116-Dnmt1 ∆3-5 cells was performed using Lipofectamin 3000 Reagent 20 proteomic analysis by data independent mass spectrometry analysis.
Figure 2
A. Gene Ontology terms enriched in the proteome from HCT116-Dnmt1 ∆3-5 cells. Gene 25 Ontology terms from the set of significantly (p<0.05) differential increased proteins in hypomorph cells. Selected GO terms where p-value <0.05 and the rank difference between hypomorph and wild-type GO terms are shown.
B. Gene Ontology terms enriched in the proteome from HCT116-Dnmt1 WT cells. Gene 30 Ontology terms from the set of significantly (p<0.05) differential increased proteins in wild-type cells. Selected GO terms where p-value <0.05 and the rank difference between wild-type and hypomorph GO terms are shown.
C. Network analysis of proteins with differential abundance in HCT116-Dnmt1 ∆3-5 cells. 5 Selected differential protein interaction-networks are shown (Catenin-EMT network coloured according to mutant/wild-type abundance ratio. Nodes in grey indicate proteins not identified in the mass-spectrometry datasets but analysed by Western blot. Protein interaction networks were identified using Pathway Studio and String DB, using evidence-based directional interaction search settings. Networks were then extracted and manually pseudo-coloured to 10 articulate differential abundance change in the nuclear proteomic profile of HCT116-Dnmt1 ∆3-5 cells. 
